| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.056 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |